tiprankstipranks

John Cox Insider Profile

4 Followers
John Cox, EVP Pharmaceutical Oper & Tech at Biogen, holds 0.00 shares in Sigilon Therapeutics (Ticker: SGTX), holds 923.00 shares in Repligen (Ticker: RGEN), holds 0.00 shares in Bioverativ Inc (Ticker: BIVV).
tipranks
John Cox

John Cox
Biogen (BIIB)
EVP Pharmaceutical Oper & Tech

Ranked #95,611 out of 98,501 Corporate Insiders

Profitable Transactions

0%
0 out of 4 Profitable Transactions

Average Return

-119.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
97.11%
2.89%
0.00%
A breakdown of John Cox's holdings

Insider Roles

Biogen
(BIIB)
EVP Pharmaceutical Oper & Tech
Repligen
(RGEN)
Director
Dyne Therapeutics
(DYN)
See Remarks, Director
Roles that John Cox holds in companies

Most Profitable Insider Trade

Stock:
Repligen
(RGEN)
Rating:Informative Sell
Date:Mar 05, 2020 - Mar 05, 2021
Return:-98.60%
The most profitable trade made by John Cox

John Cox's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Biogen
Apr 05, 2016
EVP Pharmaceutical Oper & Tech
Uninformative Buy
$4.87M
BIVV
Bioverativ Inc
Mar 08, 2018
Uninformative Sell
$0.00
SGTX
Sigilon Therapeutics
Aug 11, 2023
Uninformative Sell
$0.00
Dyne Therapeutics
See Remarks, Director
Repligen
Mar 26, 2020
Director
Informative Sell
179.71K
$144.97K
List of latest transactions for each holding click on a transaction to see John Cox's performance on stock

John Cox insider profile FAQ

What is the percentage of profitable transactions made by John Cox?
The percentage of profitable transactions made by John Cox is 0%.
    What is the average return per transaction made by John Cox?
    The average return per transaction made by John Cox is -119.60%.
      What stocks does John Cox hold?
      John Cox holds: BIIB, BIVV, SGTX, DYN, RGEN stocks.
        What was John Cox’s latest transaction?
        John Cox latest transaction was an Uninformative Sell of ―.
          What was John Cox's most profitable transaction?
          John Cox’s most profitable transaction was an Informative Sell of RGEN stock on March 5, 2020. The return on the trade was -98.60%.
            What is John Cox's role in Biogen?
            John Cox's role in Biogen is EVP Pharmaceutical Oper & Tech.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.